Stocks and InvestingStocks and Investing
Thu, February 22, 2024
Wed, February 21, 2024
Tue, February 20, 2024

Olivia Brayer Reiterated (VRTX) at Buy and Held Target at $440 on, Feb 20th, 2024


Published on 2024-10-28 09:03:57 - WOPRAI, Olivia Brayer
  Print publication without navigation


Olivia Brayer of Cantor Fitzgerald, Reiterated "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $440 on, Feb 20th, 2024.

Olivia has made no other calls on VRTX in the last 4 months.



There are 15 other peers that have a rating on VRTX. Out of the 15 peers that are also analyzing VRTX, 6 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $420 on, Tuesday, February 6th, 2024
  • Liisa Bayko of "Evercore ISI Group" Downgraded from Buy to Hold and Increased Target to $438 on, Tuesday, February 6th, 2024
  • William Pickering of "Bernstein" Downgraded from Buy to Hold on, Friday, February 2nd, 2024
  • Naz Rahman of "Maxim Group" Downgraded from Strong Buy to Hold on, Wednesday, January 31st, 2024
  • Paul Matteis of "Stifel" Reiterated at Hold and Held Target at $373 on, Wednesday, November 22nd, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $364 on, Wednesday, November 8th, 2023


These are the ratings of the 9 analyists that currently disagree with Olivia


  • Andy Chen of "Wolfe Research" Initiated at Buy on, Thursday, February 15th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $540 on, Tuesday, February 6th, 2024
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $472 on, Tuesday, February 6th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $450 on, Tuesday, February 6th, 2024
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $457 on, Tuesday, February 6th, 2024
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $508 on, Wednesday, January 31st, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $559 on, Wednesday, January 31st, 2024
  • Whitney Ijem of "Canaccord Genuity" Downgraded from Hold to Strong Sell and Increased Target to $379 on, Wednesday, January 24th, 2024
  • Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $415 on, Tuesday, November 7th, 2023